Advertisement

Health


Needle-phobes rejoice: NeedleCalm launches in Australia

Needle-phobes rejoice: NeedleCalm launches in Australia

An innovative piece of medical technology aimed at reducing physi...

Medibank profit rises, CEO Craig Drummond to depart

Medibank profit rises, CEO Craig Drummond to depart

Private health insurance provider Medibank (ASX: MPL) has capital...

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Starpharma's anti-COVID nasal spray approved in Europe and the UK

Australian pharmaceutical company Starpharma's (ASX: SPL) ant...

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Mitigation measures against COVID-19 led to a drastic reduction i...

Profits double for IVF specialist Virtus Health

Profits double for IVF specialist Virtus Health

As the leading assisted reproductive services (ARS) company ...

Advertisement
Advertisement
Advertisement
Noxopharm study results herald "new era" for prostate cancer treatment

Noxopharm study results herald "new era" for prostate cancer treatment

A trial of Noxopharm's (ASX: NOX) prostate cancer treatment h...

What's the difference between mutations, variants and strains? A guide to COVID terminology

What's the difference between mutations, variants and strains? A guide to COVID terminology

Living through a global pandemic over the past year has seen all ...

Mesoblast rises on positive back pain trial results

Mesoblast rises on positive back pain trial results

Positive results from stem cell research company Mesoblast's ...

Eyes and ears on Healthia as shares double in four months

Eyes and ears on Healthia as shares double in four months

Investors appeared to take little notice of allied health group H...

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Medicinal cannabis cultivator and manufacturer Little Green Phar...

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Cynata Therapeutics (ASX: CYP), founded by two clever stem cell r...

How Smiles Inclusive was turned upside down: A timeline of decay

How Smiles Inclusive was turned upside down: A timeline of decay

For retail investors there is something very reassuring about put...

AnteoTech spikes on customer Ellume's $304m US contract news

AnteoTech spikes on customer Ellume's $304m US contract news

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: A...

Ellume secures $304m US Government contract to scale up COVID-19 test production

Ellume secures $304m US Government contract to scale up COVID-19 test production

Brisbane-based diagnostics company Ellume has today announced a U...

Tomas Steenackers mimics National Vet Care with new optometry venture

Tomas Steenackers mimics National Vet Care with new optometry venture

After the ASX-listed company he founded was offered a $251.5 mill...

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Medicinal cannabis company Little Green Pharma (ASX: LGP) is toda...

Immutep's EAT COVID trial progresses to the next phase

Immutep's EAT COVID trial progresses to the next phase

A trial of biotechnology company Immutep's (ASX: IMM) experim...

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's (ASX: ADO) plans to bring a rapid COVID-19 test t...

Ecofibre signs "milestone" international distribution deal for CBD products

Ecofibre signs "milestone" international distribution deal for CBD products

A new deal between Ecofibre (ASX: EOF) and Sydney-based pharmaceu...

Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets

Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets

After 10 months at the helm of embattled Gold Coast-based dental ...

Advertisement

Partner Content

It's fair to say that at the start of 2020, few would have pr...
Momentum for cannabis stocks continues to intensify, as internati...
ESG (Environment, Social, Governance) has become essential in bus...
While some prefer to invest their money in stocks, bonds or prope...
If intellectual property (IP) is what differentiates a business f...
The COVID-19 pandemic has fundamentally changed the way Australia...
Curtin University and Extreme Tech Challenge (XTC) have partnere...
Due diligence is paramount for responsible lending, but that does...
After seeing how expensive and time-consuming it was for the mili...
Upskilling was the name of the game when energy specialist Jessie...
Advertisement